Did you know that you can report problems that you have had with drugs and other medical products to the FDA? Did you know that MedWatch can send safety alerts directly to you, as soon as they appear on the web site?

The FDA will host a webinar “FDA’s MedWatch System: How to Report Adverse Events”. The featured speaker, Brenda Rose Pharm.D., a Health Programs Coordinator in FDA’s Office of Special Health Issues will give an overview and answer questions about how to report adverse events to MedWatch.

The free 30 minute webinar will be held Thursday, October 20th at 11 AM ET.

There are a limited number of spots available for the webinar. Materials from the webinar will also be made available on the FDA website following the presentation.

Generic Dilantin may be problem for those who have seizures. Since the generic causes most people who switch to have low blood level and must take more medication. All manufacturers of generic Dilantin use other chemicals and these are different. This is putting people at risk. Pharmacies are competitive and will buy drugs from whatever manufacturer is cheapest. This will mean the generic will not always be the same. I hope someone will realize that controlling seizures is an extremely sensitive. Process. Making Dilantin a tier 4 medication is perhaps setting many people at risk for seizure because they cannot afford Dilantin. Hospitals will have more emergency visits.

I did not know that we could watch these webinars on-line. I am a web designer, and I will look into set this up on websites that I put together for my clients. It is a great way to drive more traffic to your blog.